Zura bio limitedZURA.US Overview

US StockHealthcare

(No presentation for ZURA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

ZURA Overall Performance

ZURA AI Analysis & Strategy

ZURA Recent Performance

1.65%

Zura bio limited

0.81%

Avg of Sector

-1.14%

S&P500

ZURA PowerScanner

ZURA Key Information

ZURA Valuation Metrics

ZURA Earnings Table

ZURA Profile

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.